GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Medtox Scientific, Inc. (MTOX) [hlAlert]

Rating:
Buy MTOX
up 84.41 %

Medtox Scientific, Inc. (MTOX) rated Buy with price target $20 by Next Generation

Posted on: Tuesday,  Mar 25, 2008  12:25 PM ET by Next Generation

Next Generation rated Buy Medtox Scientific, Inc. (NASDAQ: MTOX) on 03/25/2008, when the stock price was $14.63. Since
then, Medtox Scientific, Inc. has gained 84.42% as of 07/31/2012's recent price of $26.98.
If you would have followed this Next Generation's recommendation on MTOX, you would have gained 84.41% of your investment in 1589 days.

MEDTOX Scientific, Inc. (MEDTOX) provides forensic and clinical laboratory services through its wholly owned subsidiary, MEDTOX Laboratories, Inc., and manufactures and distributes diagnostic devices and other similar products through its other wholly owned subsidiary, MEDTOX Diagnostics, Inc. It operates in two segments: Laboratory Services, which consists of the activities conducted by MEDTOX Laboratories, Inc. and New Brighton Business Center LLC, and Product Sales, conducted by MEDTOX Diagnostics, Inc. Laboratory Services include forensic toxicology, clinical toxicology, clinical testing for the pharmaceutical industry (central laboratory services, bioanalytical and pharmacokinetic testing), clinical testing for occupational health clinics and analysis of heavy and trace metals. The Product Sales segment includes sales of a variety of on-site drug screening products and contract manufacturing.

Next Generation Equity Research, LLC is an equity research boutique focused on the needs of the institutional investor. Our mission is to provide unbiased, idea-driven research on small to mid cap-sized companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/25/2008 12:25 PM Buy
None
14.63 20.00
as of 12/24/2008
1 Week up  16.50 %
1 Month up  17.82 %
3 Months up  40.00 %
1 YTD up  1.33 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy